yes and no, it was Covid FOMO and ex-direector(s) selling down. Plus reformulation not commencing until 2022 and completed 2024 when cardio protection was the whole idea from 2019/2020 but took years to get underway / whilst pursing an obsolete RC110.
DrT acknowledged reformulation commencement
was delayed and took responsibility in the past. Let’s move on from that. Tox studies ‘imminent’ and P1A/1B on the horizon so things looking more promising with CPACS-F validation.
Same thing recently played out in PAA required
a board spill was required to get the same result. I think the misalignment of previous board was an anchor now removed so full steam ahead.
Benefit of hindsight is always 20/20.
Ann: Application for quotation of securities - RAC, page-21
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.050(3.13%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.70 | $1.52 | $318.0K | 193.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 496 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 5484 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |